MARDX LYME DISEASE IGG IFA TEST SYSTEM

Reagent, Borrelia Serological Reagent

MARDX DIAGNOSTICS, INC.

The following data is part of a premarket notification filed by Mardx Diagnostics, Inc. with the FDA for Mardx Lyme Disease Igg Ifa Test System.

Pre-market Notification Details

Device IDK890053
510k NumberK890053
Device Name:MARDX LYME DISEASE IGG IFA TEST SYSTEM
ClassificationReagent, Borrelia Serological Reagent
Applicant MARDX DIAGNOSTICS, INC. 847 JERUSALEM RD. Scotch Plains,  NJ  07076
ContactArthur Markovits
CorrespondentArthur Markovits
MARDX DIAGNOSTICS, INC. 847 JERUSALEM RD. Scotch Plains,  NJ  07076
Product CodeLSR  
CFR Regulation Number866.3830 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received1989-01-06
Decision Date1989-04-18

NIH GUDID Devices

Device IdentifiersubmissionNumberSupplement
05391516747608 K890053 000
05391516746373 K890053 000
05391516746182 K890053 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.